You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
On August 28, 2019, Medtronic announced that Geoff Martha was appointed Medtronic President and a member of the Medtronic Board of Directors, effective November 1, 2019. Martha will succeed Omar Ishrak as CEO on April 27, 2020. Announcement can be seen here.
Geoff Martha became President of Medtronic on Nov. 1, 2019. Medtronic is the world’s leading medical technology company, with $30 billion in annual revenue, and operations reaching more than 150 countries worldwide. Medtronic offers technologies and solutions to treat a wide range of medical conditions, including cardiac and vascular diseases, respiratory, neurological and spinal conditions, diabetes, and more.
Prior to assuming this role, Geoff served as Executive Vice President and President of Medtronic’s Restorative Therapies Group (RTG) — one of four Medtronic business groups — with over $8B in annual revenue and approximately 14,000 employees worldwide. In that position, Geoff had global responsibility for RTG’s four divisions, which include Brain Therapies, Pain Therapies, Specialty Therapies and Spine.
Previously, Geoff was Senior Vice President of Strategy and Business Development for Medtronic and had responsibility for leading the development of Medtronic's global strategic plan, business development and acquisition-integration.
As head of Strategy and Business Development, Geoff led the acquisition of Covidien, a $10 billion global manufacturer of surgical products and supplies. The acquisition of Covidien was the largest medical technology acquisition in the history of the industry. In July 2014, he was named Chief Integration Officer to lead the integration of Covidien into Medtronic.
An ardent supporter of Medtronic-sponsored philanthropic and diversity initiatives, Geoff is a member of the Medtronic Foundation Board of Directors and serves as Medtronic’s Executive Sponsor to FIRST Robotics. He also formerly led the Medtronic African Descent Network – an internal resource group that focuses on recruitment, engagement, retention and development for employees of African descent.
Prior to joining Medtronic, Geoff served as Managing Director of Business Development at GE Healthcare, where he was responsible for global business development, including acquisitions, divestitures, joint ventures and equity investments. In his 19-year career with GE, which included significant time with GE Capital, Geoff held several executive roles in business leadership, corporate development, strategic marketing, and sales management.
Passionate about socio-economic issues, Geoff serves on the boards of two Minneapolis-based nonprofit organizations: Children’s HeartLink and Northside Achievement Zone (NAZ). Children’s HeartLink provides access to care for children around the world with congenital heart defects. NAZ is a community collaborative that works to end generational poverty and build a culture of achievement in North Minneapolis so low-income children of color graduate college and are career-ready.
Geoff received a bachelor’s degree in Finance as a member of the Scholar’s Program from Pennsylvania State University. He graduated in 1992 with highest honors. Geoff was captain of the Penn State men’s hockey team and was later inducted into its Hockey Hall of Fame in 1998. The University awarded him the 2016 Penn State Hockey Distinguished Alumni Award.